GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OSTO:BIOG B) » Definitions » Cyclically Adjusted PB Ratio

BioGaia AB (OSTO:BIOG B) Cyclically Adjusted PB Ratio : 8.45 (As of Jul. 10, 2025)


View and export this data going back to 1998. Start your Free Trial

What is BioGaia AB Cyclically Adjusted PB Ratio?

As of today (2025-07-10), BioGaia AB's current share price is kr106.50. BioGaia AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr12.60. BioGaia AB's Cyclically Adjusted PB Ratio for today is 8.45.

The historical rank and industry rank for BioGaia AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:BIOG B' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 7.81   Med: 16.38   Max: 24.51
Current: 8.46

During the past years, BioGaia AB's highest Cyclically Adjusted PB Ratio was 24.51. The lowest was 7.81. And the median was 16.38.

OSTO:BIOG B's Cyclically Adjusted PB Ratio is ranked worse than
91.3% of 747 companies
in the Drug Manufacturers industry
Industry Median: 2.03 vs OSTO:BIOG B: 8.46

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BioGaia AB's adjusted book value per share data for the three months ended in Mar. 2025 was kr17.586. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr12.60 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


BioGaia AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BioGaia AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Cyclically Adjusted PB Ratio Chart

BioGaia AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.64 14.85 9.15 9.19 9.08

BioGaia AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.95 10.55 9.39 9.08 8.74

Competitive Comparison of BioGaia AB's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Cyclically Adjusted PB Ratio falls into.


;
;

BioGaia AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioGaia AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=106.50/12.60
=8.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, BioGaia AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=17.586/132.8245*132.8245
=17.586

Current CPI (Mar. 2025) = 132.8245.

BioGaia AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 4.073 99.995 5.410
201509 4.316 100.228 5.720
201512 4.567 100.276 6.049
201603 4.384 100.751 5.780
201606 3.849 101.019 5.061
201609 4.262 101.138 5.597
201612 4.790 102.022 6.236
201703 5.284 102.022 6.879
201706 4.334 102.752 5.602
201709 4.825 103.279 6.205
201712 5.352 103.793 6.849
201803 5.842 103.962 7.464
201806 4.741 104.875 6.005
201809 5.167 105.679 6.494
201812 5.826 105.912 7.306
201903 6.235 105.886 7.821
201906 4.806 106.742 5.980
201909 5.249 107.214 6.503
201912 5.859 107.766 7.221
202003 6.308 106.563 7.863
202006 6.430 107.498 7.945
202009 6.663 107.635 8.222
202012 17.293 108.296 21.210
202103 17.802 108.360 21.821
202106 17.676 108.928 21.554
202109 18.209 110.338 21.920
202112 18.591 112.486 21.952
202203 19.377 114.825 22.414
202206 17.296 118.384 19.406
202209 18.309 122.296 19.885
202212 19.532 126.365 20.530
202303 20.666 127.042 21.607
202306 18.655 129.407 19.148
202309 19.660 130.224 20.053
202312 20.106 131.912 20.245
202403 21.470 132.205 21.571
202406 15.600 132.716 15.613
202409 16.012 132.304 16.075
202412 17.041 132.987 17.020
202503 17.586 132.825 17.586

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioGaia AB  (OSTO:BIOG B) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioGaia AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB Business Description

Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB Headlines

No Headlines